These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Challenges and Solutions for Commercial Scale Manufacturing of Allogeneic Pluripotent Stem Cell Products. Lee B; Borys BS; Kallos MS; Rodrigues CAV; Silva TP; Cabral JMS Bioengineering (Basel); 2020 Mar; 7(2):. PubMed ID: 32231012 [TBL] [Abstract][Full Text] [Related]
13. GMP-Compliant Production of Autologous Adipose-Derived Stromal Cells in the NANT 001 Closed Automated Bioreactor. Fitzgerald JC; Duffy N; Cattaruzzi G; Vitrani F; Paulitti A; Mazzarol F; Mauro P; Sfiligoj A; Curcio F; Jones DM; McInerney V; Krawczyk J; Kelly J; Finnerty A; McDonagh K; McCabe U; Duggan M; Connolly L; Shaw G; Murphy M; Barry F Front Bioeng Biotechnol; 2022; 10():834267. PubMed ID: 35356775 [TBL] [Abstract][Full Text] [Related]
14. Production of oncolytic adenovirus and human mesenchymal stem cells in a single-use, Vertical-Wheel bioreactor system: Impact of bioreactor design on performance of microcarrier-based cell culture processes. Sousa MF; Silva MM; Giroux D; Hashimura Y; Wesselschmidt R; Lee B; Roldão A; Carrondo MJ; Alves PM; Serra M Biotechnol Prog; 2015; 31(6):1600-12. PubMed ID: 26289142 [TBL] [Abstract][Full Text] [Related]
15. Novel biomanufacturing platform for large-scale and high-quality human T cells production. Ou J; Si Y; Tang Y; Salzer GE; Lu Y; Kim S; Qin H; Zhou L; Liu X J Biol Eng; 2019; 13():34. PubMed ID: 31044002 [TBL] [Abstract][Full Text] [Related]
16. A novel automated bioreactor for scalable process optimisation of haematopoietic stem cell culture. Ratcliffe E; Glen KE; Workman VL; Stacey AJ; Thomas RJ J Biotechnol; 2012 Oct; 161(3):387-90. PubMed ID: 22771559 [TBL] [Abstract][Full Text] [Related]
17. Development of an automated manufacturing process for large-scale production of autologous T cell therapies. Francis N; Braun M; Neagle S; Peiffer S; Bohn A; Rosenthal A; Olbrich T; Lollies S; Ilsmann K; Hauck C; Gerstmayer B; Weber S; Kirkpatrick A Mol Ther Methods Clin Dev; 2023 Dec; 31():101114. PubMed ID: 37790245 [TBL] [Abstract][Full Text] [Related]
18. Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies. Ganeeva I; Zmievskaya E; Valiullina A; Kudriaeva A; Miftakhova R; Rybalov A; Bulatov E Bioengineering (Basel); 2022 Dec; 9(12):. PubMed ID: 36551014 [TBL] [Abstract][Full Text] [Related]
19. Piloting a scale-up platform for high-quality human T-cells production. Selvarajan V; Teo DBL; Chang CC; Ng YL; Cheong N; Sivalingam J; Khoo SHG; Wong A; Loo BLW Front Cell Dev Biol; 2024; 12():1427171. PubMed ID: 39071806 [TBL] [Abstract][Full Text] [Related]
20. CAR-T Cell Expansion in a Xuri Cell Expansion System W25. Smith TA Methods Mol Biol; 2020; 2086():151-163. PubMed ID: 31707674 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]